Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
QiuBo Zhang, ShaoJie Chen, LinJuan Zeng, YinTing Chen, GuoDa Lian, ChenChen Qian, JiaJia Li, RuiJie Xie & Kai-Hong Huang. (2017) New developments in the early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology 11:2, pages 149-156.
Read now
Read now
Articles from other publishers (29)
Matthew T. Peller & Koushik K. Das. (2023) Blood-Based Biomarkers in the Diagnosis and Risk Stratification of Pancreatic Cysts. Gastrointestinal Endoscopy Clinics of North America 33:3, pages 559-581.
Crossref
Crossref
Ruyan Zhang, Zhiqing Zhang, Huan Du, Jiawei Wang, Xiufeng Wang, Ting Zhou & Fang Wang. (2023) A nucleolin-activated polyvalent aptamer nanoprobe for the detection of cancer cells. Analytical and Bioanalytical Chemistry 415:12, pages 2217-2226.
Crossref
Crossref
Kateryna Nesteruk, Iris J.M. Levink, Esther de Vries, Isis J. Visser, Maikel P. Peppelenbosch, Djuna L. Cahen, Gwenny M. Fuhler & Marco J. Bruno. (2022) Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma. Pancreatology 22:5, pages 626-635.
Crossref
Crossref
Annalisa Comandatore, Rita Balsano, Benoit Immordino, Davinia Arguedas, Mjriam Capula, Serena R. Baglio, Ingrid Garajovà, Umberto Malapelle, Luca Morelli & Elisa Giovannetti. (2022) “Depart from evil, and do good”: Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer. Critical Reviews in Oncology/Hematology 173, pages 103659.
Crossref
Crossref
Zahra Shokati Eshkiki, Nasibeh Khayer, Atefeh Talebi, Reza Karbalaei & Abolfazl Akbari. (2022) Novel insight into pancreatic adenocarcinoma pathogenesis using liquid association analysis. BMC Medical Genomics 15:1.
Crossref
Crossref
Jose Antonio Delgado, Maria Antonieta Ballesteros, María Magdalena Parera & Josep Miquel Bauça. (2021) Pancreatic Cancer Insights: Optimization of the Diagnostic Capacity of Tumor Biomarkers. Laboratory Medicine 52:6, pages 550-557.
Crossref
Crossref
Ali Al-Fatlawi, Negin Malekian, Sebastián García, Andreas Henschel, Ilwook Kim, Andreas Dahl, Beatrix Jahnke, Peter Bailey, Sarah Naomi Bolz, Anna R. Poetsch, Sandra Mahler, Robert Grützmann, Christian Pilarsky & Michael Schroeder. (2021) Deep Learning Improves Pancreatic Cancer Diagnosis Using RNA-Based Variants. Cancers 13:11, pages 2654.
Crossref
Crossref
Jiayu Zhang, Yue Wang, Tiancheng Zhao, Yezhou Li, Leilei Tian, Jinming Zhao & Jingxin Zhang. (2020) Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer. World Journal of Surgical Oncology 18:1.
Crossref
Crossref
Stephen P Pereira, Lucy Oldfield, Alexander Ney, Phil A Hart, Margaret G Keane, Stephen J Pandol, Debiao Li, William Greenhalf, Christie Y Jeon, Eugene J Koay, Christopher V Almario, Christopher Halloran, Anne Marie Lennon & Eithne Costello. (2020) Early detection of pancreatic cancer. The Lancet Gastroenterology & Hepatology 5:7, pages 698-710.
Crossref
Crossref
Xingcheng Xiong, Qiao Shi, Xiaojia Yang, Weixing Wang & Jing Tao. (2019) LINC00052 functions as a tumor suppressor through negatively modulating miR‐330‐3p in pancreatic cancer. Journal of Cellular Physiology 234:9, pages 15619-15626.
Crossref
Crossref
Anqi Yu, Tiffany A. Romero & Jeanine M. Genkinger. (2019) Primary and Secondary Prevention of Pancreatic Cancer. Current Epidemiology Reports 6:2, pages 119-137.
Crossref
Crossref
Eseosaserea Igbinigie, Fengbiao Guo, Shi-Wen Jiang, Cullen Kelley & Jinping Li. (2019) Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma. Clinica Chimica Acta 488, pages 226-234.
Crossref
Crossref
Haibo Xing, Jing Wang, Yanling Wang, Mengting Tong, Hong Hu, Changxin Huang & Da Li. (2018) Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis. Gastroenterology Research and Practice 2018, pages 1-9.
Crossref
Crossref
Mohamadmahdi Samandari, María Gil Julia, Alistair Rice, Antonios Chronopoulos & Armando E. del Rio Hernandez. (2018) Liquid biopsies for management of pancreatic cancer. Translational Research 201, pages 98-127.
Crossref
Crossref
S R Markar, B Brodie, S-T Chin, A Romano, D Spalding & G B Hanna. (2018) Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer. British Journal of Surgery 105:11, pages 1493-1500.
Crossref
Crossref
Meritxell Balmaña, Adrià Duran, Catarina Gomes, Esther Llop, Raquel López-Martos, M. Rosa Ortiz, Sílvia Barrabés, Celso A. Reis & Rosa Peracaula. (2018) Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. International Journal of Biological Macromolecules 112, pages 33-45.
Crossref
Crossref
Julia Baguña Torres, James C. Knight, Michael J. Mosley, Veerle Kersemans, Sofia Koustoulidou, Danny Allen, Paul Kinchesh, Sean Smart & Bart Cornelissen. (2017) Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody. Molecular Imaging and Biology 20:2, pages 292-299.
Crossref
Crossref
Cristina Jimenez-Luna, Carolina Torres, Raul Ortiz, Carmelo Dieguez, Joaquina Martinez-Galan, Consolacion Melguizo, Jose C. Prados & Octavio Caba. (2018) Proteomic biomarkers in body fluids associated with pancreatic cancer. Oncotarget 9:23, pages 16573-16587.
Crossref
Crossref
Eithne Costello. (2018) A metabolomics-based biomarker signature discriminates pancreatic cancer from chronic pancreatitis. Gut 67:1, pages 2-3.
Crossref
Crossref
Julia Mayerle, Holger Kalthoff, Regina Reszka, Beate Kamlage, Erik Peter, Bodo Schniewind, Sandra González Maldonado, Christian Pilarsky, Claus-Dieter Heidecke, Philipp Schatz, Marius Distler, Jonas A Scheiber, Ujjwal M Mahajan, F Ulrich Weiss, Robert Grützmann & Markus M Lerch. (2018) Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut 67:1, pages 128-137.
Crossref
Crossref
Lucy Oldfield, Rohith Rao, Lawrence N. Barrera & Eithne Costello. 2018. Pancreatic Cancer. Pancreatic Cancer
1241
1272
.
Xiaoqian Wang, Karolina Elżbieta Kaczor-Urbanowicz & David T. W. Wong. (2016) Salivary biomarkers in cancer detection. Medical Oncology 34:1.
Crossref
Crossref
Lucy Oldfield, Rohith Rao, Lawrence N Barrera & Eithne Costello. 2017. Pancreatic Cancer. Pancreatic Cancer
1
32
.
Evangelia Michailidou, Georgios Tzimagiorgis, Fani Chatzopoulou, Konstantinos Vahtsevanos, Konstantinos Antoniadis, Sofia Kouidou, Anastasios Markopoulos & Dimitrios Antoniades. (2016) Salivary mRNA markers having the potential to detect oral squamous cell carcinoma segregated from oral leukoplakia with dysplasia. Cancer Epidemiology 43, pages 112-118.
Crossref
Crossref
Thomas P. Potjer, Bart J. Mertens, Simone Nicolardi, Yuri E. M van der Burgt, Bert. A. Bonsing, Wilma E. Mesker, Rob A. E. M Tollenaar & Hans F. A Vasen. (2016) Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort. Translational Oncology 9:3, pages 242-247.
Crossref
Crossref
Claire Jenkinson, Victoria L. Elliott, Anthony Evans, Lucy Oldfield, Rosalind E. Jenkins, Darragh P. O'Brien, Sophia Apostolidou, Aleksandra Gentry-Maharaj, Evangelia-O Fourkala, Ian J. Jacobs, Usha Menon, Trevor Cox, Fiona Campbell, Stephen P. Pereira, David A. Tuveson, B. Kevin Park, William Greenhalf, Robert Sutton, John F. Timms, John P. Neoptolemos & Eithne Costello. (2016) Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus. Clinical Cancer Research 22:7, pages 1734-1743.
Crossref
Crossref
María José Ferri, Marc Saez, Joan Figueras, Esther Fort, Miriam Sabat, Santiago López-Ben, Rafael de Llorens, Rosa Núria Aleixandre & Rosa Peracaula. (2016) Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology. PLOS ONE 11:1, pages e0147214.
Crossref
Crossref
Sarah Heiler, Zhe Wang & Margot Zöller. (2016) Pancreatic cancer stem cell markers and exosomes - the incentive push. World Journal of Gastroenterology 22:26, pages 5971.
Crossref
Crossref
Kyoichi Takaori, Claudio Bassi, Andrew Biankin, Thomas B. Brunner, Ivana Cataldo, Fiona Campbell, David Cunningham, Massimo Falconi, Adam E. Frampton, Junji Furuse, Marc Giovannini, Richard Jackson, Akira Nakamura, William Nealon, John P. Neoptolemos, Francisco X. Real, Aldo Scarpa, Francesco Sclafani, John A. Windsor, Koji Yamaguchi, Christopher Wolfgang & Colin D. Johnson. (2016) International Association of Pancreatology (IAP)/European Pancreatic Club (EPC) consensus review of guidelines for the treatment of pancreatic cancer. Pancreatology 16:1, pages 14-27.
Crossref
Crossref